CAS: 486460-23-5; (R)-Tert-Butyl (4-Oxo-4-(3-(Trifluoromethyl)-5,6-Dihydro-[1,2,4]Triazolo[4,3-A]Pyrazin-7(8H)-yl)-1-(2,4,5-Trifluorophenyl)Butan-2-yl)Carbamate

该化合物是一个复杂的有机化合物,其特点是其独特的结构特征,包括一个氨基功能组和多种氟芳香环.该化合物展示了重要的生物活动,经常研究其在制药中的潜在应用,特别是在开发新型治疗剂方面.三氟甲基化合物的存在会加强其脂性性和代谢性稳定性,从而影响其致癌性特性.此外,三亚甲酸和丙基苯基聚醚的细胞也有可能作为生物活性分子,可能与特定生物目标发生相互作用.化合物合成通常涉及多步有机反应,突出其复杂性.与许多氟化合物一样,它可能展示其独特的溶性性和再现特性,从而形成其基本化学特性和再生的化学特性.

结构式图片

欧盟法规

C&L通报

上下游产品

3-trifluoromethyl-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine (3R)-3-[(1,1-dimethylethoxycarbonyl)amino]-4-(2,4,5-trifluorophenyl)butanoic acid tert-butyl dicarbonatedi-tert-butyl dicarbonate 2,4,5-trifluorobenzyl bromidesitagliptin phosphate (2R)-4-oxo-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine phosphate (R)-3-amino-4-(2,4,5-trifluorophenyl)butyric acid methyl ester (2R)-4-oxo-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine hydr°Chloride

合成工艺路线路线简述

  • 合成目标产物 Sitagliptin N-Boc Impurity 主要起始原料 Boc-(R)-3-Amino-4-(2,4,5-Trifluorophenyl)Butanoic Acid And 3-(Trifluoromethyl)-5,6,7,8-Tetrahydro-[1,2,4]Triazolo[4,3-A]Pyrazine Hydrochloride
  • (文献来源)合成步骤主要原料 Boc-(R)-3-Amino-4-(2,4,5-Trifluorophenyl)Butanoic Acid 和 3-(Trifluoromethyl)-5,6,7,8-Tetrahydro-[1,2,4]Triazolo[4,3-A]Pyrazine Hydrochloride
📜Boc-L-蛋氨酸置于甲醇,Sodium Hypochlorite,Sodium Tetrahydroborate,正丁基锂,2,2,6,6-四甲基哌啶氧化物,碘,异丙基溴化镁,碳酸氢钠,1-羟基苯并三唑,盐酸-N-乙基-Nˊ-(3-二甲氨基丙基)碳二亚胺,三乙胺,Sodium Bromide,碘甲烷体系中,用 四氢呋喃,甲醇,二氯甲烷,水,乙腈 作为反应溶剂,化学反应 33.33H,反应生成 N-叔丁氧羰基-西他列汀
参考文献:Intermediates Of Sitagliptin And Preparation Process Thereof
标题:Intermediates Of Sitagliptin And Preparation Process Thereof
摘要:揭示了西他列汀的中间体,其制备过程以及利用这些中间体合成西他列汀的方法.西他列汀是通过使用手性氨基化合物作为原料合成的,无需通过手性不对称催化氢化建立手性中心,并且避免了高压氢化反应.

海关参考信息

专利信息


专利号:US-8846916-B2
优先权日:2009-05-11
标题:Sitagliptin synthesis
发明人:GORE VINAYAK GOVIND; GADAKAR MAHESHKUMAR; BHOSLE PRIYANKA; SHINDE SURESH
权利人:GORE VINAYAK GOVIND; GADAKAR MAHESHKUMAR; BHOSLE PRIYANKA; SHINDE SURESH; GENERICS UK LTD
摘要:The present invention relates to novel processes for the preparation of enantiomerically enriched β-amino acid derivatives such as β-amino esters useful for the synthesis of enantiomerically enriched biologically active molecules such as sitagliptin. The key step involves the resolution of the racemate with mandelic acid.

专利号:WO-2009064476-A1
优先权日:2007-11-13
标 题 :Preparation of sitagliptin intermediate
发明人:PERLMAN NURIT; ETINGER MARINA; NIDDAM-HILDESHEIM VALERIE; ABRAMOV MILI
权利人:TEVA PHARMA; TEVA PHARMA; PERLMAN NURIT; ETINGER MARINA; NIDDAM-HILDESHEIM VALERIE; ABRAMOV MILI
摘要:Intermediate compounds in the synthesis of Sitagliptin, 3-amino-4-(2,4,5- trifluorophenyl)but-2-enoic acid alkyl ester, and amino protected-3-amino-4-(2,4,5- trifluorophenyl)but-2-enoic acid alkyl ester, and the stereoselective reduction of these compound to give Synthon I, or the amino-protected Synthon I, are provided.

专利号:US-2009192326-A1
优先权日:2007-11-13
标题 :Preparation of sitagliptin intermediate
发明人:PERLMAN NURIT; ETINGER MARINA; NIDDAM-HILDESHEIM VALERIE; ABRAMOV MILI
权利人:PERLMAN NURIT; ETINGER MARINA; NIDDAM-HILDESHEIM VALERIE; ABRAMOV MILI
摘要:Intermediate compounds in the synthesis of Sitagliptin, 3-amino-4-(2,4,5-trifluorophenyl)but-2-enoic acid alkyl ester, and amino protected-3-amino-4-(2,4,5-trifluorophenyl)but-2-enoic acid alkyl ester, and the stereoselective reduction of these compound to give Synthon I, or the amino-protected Synthon I, are provided.

专利号:US-8471057-B2
优先权日:2009-09-27
标 题:Sitagliptin intermediates, preparation methods and uses thereof
发明人:ZHU GUOLIANG; ZHANG JIAN; YANG LIJUN; YAO QINGDAN; YING JIE
权利人:ZHU GUOLIANG; ZHANG JIAN; YANG LIJUN; YAO QINGDAN; YING JIE; ZHEJIANG JIUZHOU PHARM CO LTD
摘要:The present invention relates to Sitagliptin intermediate and preparation method and use thereof. The method comprises reacting compound of formula (II) and trifluorobromobenzene with a Grignard reagent by a Grignard reaction to obtain a compound of formula (I). Compound of formula (I) is a new intermediate compound for the synthesis of Sitagliptin. Compound of formula (I) can be easily used for preparing another important intermediate compound of formula (V) for the synthesis of Sitagliptin. The structures of the compounds mentioned above are as the following:

专利号:JP-6199556-B2
优先权日:2009-05-11
标题:Synthesis of sitagliptin

专利号:JP-2016029051-A
优先权日:2009-05-11
标题 :Synthesis of sitagliptin

供应商参考报价(招募中)

品牌试剂参考报价(招募中)

📌 第三方产品分析报告

✅ COA系统入驻 | 共享模式

合成参考文献


摘要:Kleemann, A.; Engel, J.; Kutscher, B.; Reichert, D., Pharmaceutical Substances[Online], Thieme: Stuttgart, (2007).
📝 需求与反馈
尽可能描述清楚需求与问题信息
×

通知